NKE News 72.92 05/02/2014 06:02:19 Nike Inc (NKE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nike Inc (NKE) 72.92 $NKE

LeapFrog Hops on a New Craze
Rick Munarriz, The Motley Fool - Motley Fool - Thu May 01, 10:54AM CDT
LeapFrog cashed in on the tablet craze a couple of years ago, and now it's making a splash in another hot trend. LeapFrog is unveiling  LeapBand this morning, billed as the first wearable activity tracker for kids. Kids score points through...

Stock Price Movements, Women's Half Marathon, Launch of New Programs, and Quarterly Earnings Release - Analyst Notes on Mondelez, Nike, Kimberly-Clark, International Paper and Mattel
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Mondelez International Inc. (NASDAQ: MDLZ), Nike Inc. (NYSE: NKE), Kimberly-Clark Corp. (NYSE: KMB), International Paper Company (NYSE: IP) and Mattel Inc. (NASDAQ: MAT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1892-100free.

Jim Cramer's 'Mad Money' Recap: 5 Companies To Bank On
at The Street - Wed Apr 30, 5:59PM CDT
Cramer celebrated another high for the Dow and CNBC's 25th anniversary with five can't-miss stocks.

This Apparel Company Looks Like a Winner
Andrés Cardenal, The Motley Fool - Motley Fool - Wed Apr 30, 3:00PM CDT
Source: VF Corporation. VF Corporation reported solid financial performance for the first quarter of 2014 thanks to strength in its outdoor and sports segment. Besides, the company looks attractive in comparison to competitors such as Nike ...

VF Just Proved Its Growth Strategy Is Working
Philip Saglimbeni, The Motley Fool - Motley Fool - Wed Apr 30, 11:22AM CDT
The latest results from global apparel company VF Corporation  indicate that the company is well on its way to achieving management's previously stated aggressive growth goals. The company's core brands remain incredibly strong, and management is...

Jim Cramer: Spend Is a Four-Letter Word
at The Street - Wed Apr 30, 10:26AM CDT
The market wants companies that are taking share with minimal spending.

Is Nike Rebounding in China?
Chris Brantley, The Motley Fool - Motley Fool - Wed Apr 30, 8:00AM CDT
After its China sales declined for three consecutive quarters (the third quarter of 2013 through the first quarter of 2014), Nike   began to turn things around in the second quarter of 2014. The growth continued in the third quarter, although future...

Activist: 1 detained after China factory strike
AP - Wed Apr 30, 4:06AM CDT
BEIJING (AP) — Police detained a labor rights activist following a strike by 40,000 employees at a factory that makes shoes for Adidas and Nike, his colleague said Wednesday.

Should You Buy These 4 Activewear Stocks?
Brian Nichols, The Motley Fool - Motley Fool - Tue Apr 29, 12:31PM CDT
Nike , Under Armour , lululemon athletica  , and now Hanesbrands are all part of the activewear segment. And besides Hanesbrands, all have traded lower since March. Therefore, with each company continuing to grow while valuation multiples...

NIKE Falls 1.42% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 28, 4:11PM CDT
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $71.10 to a high of $73.69. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $72.51 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Skechers Outruns the Competition
Daniel James, The Motley Fool - Motley Fool - Mon Apr 28, 4:00PM CDT
Retail earnings were hit hard more or less across the board this winter, as extreme weather put a drag on store traffic. Brick-and-mortar retailers in various industries were affected, from electronics stores to apparel chains. However, some...

Will Companhia Brasileira de Distribuicao (CBD) Beat Sales Ests? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 3:00PM CDT
Companhia Brasileira de Distribuicao (CBD) is set to report its first quarter 2014 results on Apr 29 after the market closes.

Under Armour Crushes Earnings, Yet Again
Philip Saglimbeni, The Motley Fool - Motley Fool - Mon Apr 28, 1:54PM CDT
The massive wave of success that athletic apparel, footwear, and accessories manufacturer Under Armour is currently riding shows no sign of stopping anytime soon. The company's first-quarter earnings results prove that Under Armour is the best...

2 Reasons Not to Sell the Dow in May
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 28, 11:30AM CDT
The Dow Jones Industrials  had climbed 66 by early afternoon trading Monday, bouncing back from geopolitical and macroeconomic fears late last week as favorable earnings news helped bolster confidence once more. Those with a somewhat longer-term...

Can Iconix Group (ICON) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 11:30AM CDT
Iconix Brand Group Inc. (ICON) is set to report its first quarter 2014 results on Apr 30 before the market opens. Last quarter, it posted a positive surprise of 5.90%. Let's see how things are shaping up for this announcement.

Can Shoes Drive This Athletic-Apparel Market Higher?
Marshall Hargrave, The Motley Fool - Motley Fool - Sun Apr 27, 6:00AM CDT
Under Armour has been a fantastic pick for investors. Shares are up nearly 1,000% over the last five years. The company came through with another solid quarter during the fourth quarter. Earlier this year Under Armour posted that both revenue and...

How Simple Math and a Nike Cultural Imperative Might Have Killed Fuelband
David Stern, The Motley Fool - Motley Fool - Sat Apr 26, 4:00PM CDT
This story originally written by David Stern at  CITEworld . Sign up for our  free newsletter here. It's nice to be right once in a while. In December, I had the distinct pleasure of speaking on a panel at the Wearables Technology Expo,...

Is $40 the End of Skechers’ Bullish Road?
Brian Nichols, The Motley Fool - Motley Fool - Fri Apr 25, 7:05PM CDT
Skechers has a long and storied history of going from hot to cold and then back to hot again. On four separate occasions since the year 2001, Skechers' stock has seen $40 a share only to fall below $12 a share. Now, once more exceeding $40...

This Week's 5 Dumbest Stock Moves
Rick Munarriz, The Motley Fool - Motley Fool - Fri Apr 25, 3:45PM CDT
Stupidity is contagious -- even respectable companies can catch it. As we do every week, let's take a look at five dumb financial events this week that may make your head spin. 1. America isn't riding on Dunkin' It's never cool to offer up a...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Updated Category News Views 64

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Continue Reading
Cloopen Group's Private Transition: What Investors Should Know

Updated Category News Views 121

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 0

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Freddy’s Joins Hershey For a Limited-Time Flavor Fest

Updated Category News Views 95

The Sweet Collaboration We Didn't See Coming Well, folks, here's a tasty twist for you—Freddy's Frozen Custard & Steakburgers is cozying up to The Hershey Company to bring a sugar rush to our mundane lives. Starting Nov. 4, they're rolling out a limited-time series of treats so indulgent you'll want to skip straight to dessert. And if that wasn't enough, they're...

Continue Reading
Bloomberg Law Integrates Docket Data with AI Platform

Updated Category News Views 0

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 67

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
Genedata's New ELN Transforms Biopharma R&D Workflows

Updated Category News Views 58

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

Continue Reading
J.H. Strain & Sons' Asset Sale Seals a New Era

Updated Category News Views 59

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 0

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading

Top 5 Most Recently Viewed Articles

Lilly Flexes Oncology Muscle at 2026 ASCO Meet

Updated Category News Views 19

Lilly's Pipeline Gets the Spotlight With the ASCO conference kicking off in Chicago this year, Eli Lilly (NYSE: LLY) is coming in guns blazing. The company's oncology roster is vast and spread across a variety of tumor types and treatment modalities. This year's presentations are dripping with promise. You got Retevmo leading the charge in a plenary session, joined by...

Continue Reading
David Brenneman Strengthens Antitrust Practice at Latham

Updated Category News Views 212

David Brenneman Joins Latham & Watkins Latham & Watkins LLP is excited to announce a significant addition to their Antitrust & Competition Practice. Renowned antitrust lawyer David Brenneman has joined their Washington, D.C. office as a partner. Brenneman brings considerable expertise in managing the antitrust aspects of various mergers and acquisitions, enhancing the...

Continue Reading
Join the Class Action for Viatris Inc.: Important Updates

Updated Category News Views 419

Understanding the Viatris Class Action Opportunity Attention, investors! If you've purchased securities of Viatris Inc. (NASDAQ: VTRS), this is a critical time for you. The Rosen Law Firm, renowned for advocating investor rights globally, is reaching out to individuals who bought Viatris stocks during an identified time frame. Having knowledge of these events is essential...

Continue Reading
Transformative Health Education: Empowering Future Generations

Updated Category News Views 120

Understanding the Growing Health Crisis A crisis is quietly unfolding in classrooms across the nation: rising rates of preventable chronic illnesses, mental health struggles, and pervasive health illiteracy are significantly impacting the wellness of today's youth. In the face of these alarming statistics, Know Yourself Academy emerges as a beacon of hope, aiming to...

Continue Reading
Free Guide by Pacific Mind Health Eases Anxiety

Updated Category News Views 11

Wrestling with Your Inner Spotlight? Pacific Mind Health Steps In There's a good chance most of us have been there—sweatin' the small stuff like we're the star attraction in the circus of life, convinced everyone else is watching as we trip over our own shoelaces. Well, don't sweat it. Pacific Mind Health has jumped in to lend a hand with some real tools to shake off...

Continue Reading